AstraZeneca has begun the global withdrawal of its Covid-19 vaccine Vaxzevria, citing a surplus of updated vaccines.
The firm said the decision was taken because of a decline in demand for the vaccine.
AstraZeneca had recently admitted in court documents that its vaccine against Covid-19 has the potential to cause TTS, a rare ...
Drugmaker AstraZeneca is reportedly pulling its COVID-19 vaccine from global markets due to a surplus of updated alternatives ...
"As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the ...
AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision. It said the rise of new coronavirus variants meant demand had shifted to the newer updated vaccines.
, opens new tab said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic. The company also said it ...
The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development. AstraZeneca said on Tuesday it had ...
AstraZeneca has begun the global withdrawal of its Covid-19 vaccine, Vaxzevria, citing a surplus of updated vaccines designed to combat new virus variants. The European Medicines Agency (EMA ...
The company faced a class-action lawsuit that claimed the vaccine caused TTS – which stands for Thrombosis with ...
AstraZeneca will withdraw its coronavirus vaccines, British media reported Wednesday. The decision by the British-Swedish ...
AstraZeneca's Covid-19 vaccine is associated with another rare but fatal blood clotting disorder, according to new findings ...